+51 (01) 372 0872
administracion@drintefa.com.pe



PHARMACOVIGILANCE

DRINTEFA is concerned about the well-being and safety of the patient, which is why it has incorporated the area of ​​pharmacovigilance, whose main objective is to contribute to the protection of the patient by promoting the safe and effective use of medications, and providing timely information.


Welcome Pharmacovigilance
Pharmacovigilance is a responsibility

What is Pharmacovigilance?

It is the science and activities related to the detection, evaluation, understanding and prevention of adverse events of pharmaceutical products or any other possible problem related to them (WHO, 2002)

What is the objective of Pharmacovigilance?

1.- Systematically evaluate adverse reactions to medications.
2.- Prevent or reduce harmful effects for the patient and thus improve public health.
3.- Ensure the care and safety of patients in relation to the use of medicines.

Why is Pharmacovigilance important?

1.- It allows you to check the level of effectiveness and safety that a product offers after a period of uninterrupted use.
2.- Allows you to detect rare RAM.
3.- Studies carried out in animals do not reflect, in their entirety, the behavior of medications in humans.

What is an adverse drug reaction (ADR)?

It is a harmful and unwanted effect that occurs at usual doses used in humans for prophylaxis or treatment of diseases to modify physiological functions.


What should be reported?

1.- Any unwanted effect, during or after the administration of any of our products.
2.- Overdose cases.
3.- Misuse of DRINTEFA S.A. products


Who to report to?


It must be reported to the Pharmacovigilance Team of DRINTEFA S.A.
Telephone: +51 (01) 372 0872 | Cell: +51 987 511 950
Email: pharmacovigilancia@drintefa.com
It can be reported orally or in writing (phone call, interview, letter, e-mail, etc.)